BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6682006)

  • 1. Steroid stimulation of plasminogen activator production in a human breast cancer cell line (MCF-7).
    Butler WB; Kirkland WL; Gargala TL; Goran N; Kelsey WH; Berlinski PJ
    Cancer Res; 1983 Apr; 43(4):1637-41. PubMed ID: 6682006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responses to retinoic acid of tamoxifen-sensitive and -resistant sublines of human breast cancer cell line MCF-7.
    Butler WB; Fontana JA
    Cancer Res; 1992 Nov; 52(22):6164-7. PubMed ID: 1423259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
    Sheen YY; Ruh TS; Mangel WF; Katzenellenbogen BS
    Cancer Res; 1985 Sep; 45(9):4192-9. PubMed ID: 4040807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of serum and insulin on the sensitivity of the human breast cancer cell line MCF-7 to estrogen and antiestrogens.
    Butler WB; Kelsey WH; Goran N
    Cancer Res; 1981 Jan; 41(1):82-8. PubMed ID: 7004631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells.
    Katzenellenbogen BS; Norman MJ; Eckert RL; Peltz SW; Mangel WF
    Cancer Res; 1984 Jan; 44(1):112-9. PubMed ID: 6537799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration.
    Briand P; Lykkesfeldt AE
    Cancer Res; 1984 Mar; 44(3):1114-9. PubMed ID: 6362856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle analysis of estrogen stimulation and antiestrogen inhibition of growth of the human breast cancer cell line MCF-7.
    Lykkesfeldt AE; Larsen JK; Christensen IJ
    Breast Cancer Res Treat; 1986; 7 Suppl():S83-90. PubMed ID: 3742066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine-responsive pancreatic carcinoma: steroid binding and cytotoxicity studies in human tumor cell lines.
    Benz C; Hollander C; Miller B
    Cancer Res; 1986 May; 46(5):2276-81. PubMed ID: 3697973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting actions of tamoxifen on endometrial and breast tumor growth in the athymic mouse.
    Gottardis MM; Robinson SP; Satyaswaroop PG; Jordan VC
    Cancer Res; 1988 Feb; 48(4):812-5. PubMed ID: 3338079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term cultivation of a human breast cancer cell line, MCF-7, in a chemically defined medium. Effect of estradiol.
    Briand P; Lykkesfeldt AE
    Anticancer Res; 1986; 6(1):85-90. PubMed ID: 3513694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal modulation of plasminogen activator: an approach to prediction of human breast tumor responsiveness.
    Mira-y-Lopez R; Ossowski L
    Cancer Res; 1987 Jul; 47(13):3558-64. PubMed ID: 3107811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
    Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
    Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a direct growth-stimulating effect of estradiol on human MCF-7 cells in vivo.
    Huseby RA; Maloney TM; McGrath CM
    Cancer Res; 1984 Jun; 44(6):2654-9. PubMed ID: 6722798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of human breast epithelial cells in vitro to hormones and drugs.
    Calaf GM
    Int J Oncol; 2006 Feb; 28(2):285-95. PubMed ID: 16391781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ; Raney S
    Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in transforming growth factor-alpha and -beta production and cell responsiveness during the progression of MCF-7 human breast cancer cells to estrogen-autonomous growth.
    Herman ME; Katzenellenbogen BS
    Cancer Res; 1994 Nov; 54(22):5867-74. PubMed ID: 7954416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture.
    Osborne CK; Boldt DH; Estrada P
    Cancer Res; 1984 Apr; 44(4):1433-9. PubMed ID: 6704960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratinocyte growth factor (KGF) induces aromatase activity in cultured MCF-7 human breast cancer cells.
    Zhang Y; Kulp SK; Sugimoto Y; Farrar WB; Brueggemeier RW; Lin YC
    Anticancer Res; 1998; 18(4A):2541-6. PubMed ID: 9703907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can transforming growth factor-beta1 and retinoids modify the activity of estradiol and antiestrogens in MCF-7 breast cancer cells?
    Czeczuga-Semeniuk E; Anchim T; Dziecioł J; Dabrowska M; Wołczyński S
    Acta Biochim Pol; 2004; 51(3):733-45. PubMed ID: 15448735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.